0618 GMT - AXA can eye faster top-line growth ahead, writes Michael Huttner, insurance analyst at Berenberg. The French insurer booked some 8% growth in its health-insurance business over the first quarter, it said in an update earlier this month. "We believe that this growth will likely accelerate because AXA has now put in place the means to control claims costs and keep pricing at affordable levels within all its main units," Huttner tells investors in a note. Berenberg has a 57.40-euro target on the stock. ((joshua.kirby@wsj.com; @joshualeokirby))
(END) Dow Jones Newswires
May 26, 2026 02:18 ET (06:18 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.